Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models
Chi-Heng Wu, Linlin Wang, Chen‐Yen Yang, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2290-2302
Open Access | Times Cited: 18

Showing 18 citing articles:

The functional and clinical roles of liquid biopsy in patient-derived models
Ziqing Zhu, Erya Hu, Hong Shen, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 27
CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy
Shanshan Guo, Wen Lei, Xueli Jin, et al.
Blood Advances (2024) Vol. 8, Iss. 11, pp. 2635-2645
Open Access | Times Cited: 10
NEW DIAGNOSTIC BIOMARKERS FOR EARLY STAGES OF CUTANEOUS T-CELL LYMPHOMA
Olga A. Gafurova, Oleg Danilik, O.V. Anufrieva, et al.
Molekulyarnaya Meditsina (Molecular medicine) (2025), pp. 18-23
Closed Access
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Esther Wei Yin Chang, Ya Hwee Tan, Jason Yongsheng Chan
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
A mechanistic, functional, and clinical perspective on targeting CD70 in cancer
Sandeep Kumar, Sowdhamini Mahendiran, Rakesh Sathish Nair, et al.
Cancer Letters (2024) Vol. 611, pp. 217428-217428
Open Access | Times Cited: 4
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications
Wenli Zhang, Mengmeng Liu, Wei Li, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 7, pp. 776-790
Open Access | Times Cited: 3
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
Swaminathan P. Iyer, R. Alejandro Sica, P. Joy Ho, et al.
The Lancet Oncology (2024)
Closed Access | Times Cited: 3
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents
Mario L. Marques‐Piubelli, Bijender Kumar, Rafet Başar, et al.
Virchows Archiv (2024) Vol. 485, Iss. 5, pp. 937-941
Open Access | Times Cited: 2
Antibody-Based Therapies for Peripheral T-Cell Lymphoma
Nazila Shafagati, Suman Paul, Sima Rozati, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3489-3489
Open Access | Times Cited: 2
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
Ugo Testa, Patrizia Chiusolo, Elvira Pelosi, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024031-e2024031
Open Access | Times Cited: 1
CD70 is a potential target biomarker in peripheral T‐cell lymphomas
Mario L. Marques‐Piubelli, Jason Sagert, Minh Thu Pham, et al.
Histopathology (2022) Vol. 81, Iss. 2, pp. 272-275
Closed Access | Times Cited: 5
Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies
Till Braun, Alexandra Schrader
Cancers (2023) Vol. 15, Iss. 9, pp. 2532-2532
Open Access | Times Cited: 2
“Next top” mouse models advancing CTCL research
Yixin Luo, Frank R. de Gruijl, Maarten H. Vermeer, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Single cells and TRUST4 reveal immunological features of the HFRS transcriptome
Ran Xiao, Lin Mu, Mubo Liu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
New and emerging therapies in cutaneous T-cell lymphoma
Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, et al.
Dermatology Reports (2024)
Open Access
CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder
Julia Richter, Ilske Oschlies, Katharina Kock, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 2, pp. 189-197
Open Access | Times Cited: 1
Single cells and TRUST4 reveal immunological features of the HFRS transcriptome
Ran Xiao, Mu Lin, Hao Liu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top